The Charcot-Marie-Tooth diseases: how can we identify and develop novel therapeutic targets?

por Roberts, Rhys C.
Publicado 2012

Removing the idiopathic from the chronic sensory neuropathies

por Roberts, Rhys C
Publicado 2021

Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α(6) and myelin maintenance to Charcot-Marie-Tooth disease type 4C

por Vijay, Sauparnika, Chiu, Meagan, Dacks, Joel B., Roberts, Rhys C.
Publicado 2016

A dysfunctional endolysosomal pathway common to two sub-types of demyelinating Charcot–Marie–Tooth disease

por Edgar, James R., Ho, Anita K., Laurá, Matilde, Horvath, Rita, Reilly, Mary M., Luzio, J. Paul, Roberts, Rhys C.
Publicado 2020

Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis

por Sahlender, Daniela A., Roberts, Rhys C., Arden, Susan D., Spudich, Giulietta, Taylor, Marcus J., Luzio, J. Paul, Kendrick-Jones, John, Buss, Folma
Publicado 2005

The topology, structure and PE interaction of LITAF underpin a Charcot-Marie-Tooth disease type 1C

por Ho, Anita K., Wagstaff, Jane L., Manna, Paul T., Wartosch, Lena, Qamar, Seema, Garman, Elspeth F., Freund, Stefan M. V., Roberts, Rhys C.
Publicado 2016